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Abstract
Heat-shock protein (Hsp) 27 is a major intracellular molecular chaperone and controller of intracellular responses to inflamma-
tory signals. In the extracellular space, recombinant Hsp27 has been described to exert anti-inflammatory activities. The aim of
this study was to assess the association between circulating levels of Hsp27 and different types of periodontitis. Pro- and anti-
inflammatory cytokines and the stress proteins Hsp27 and Hsp60 with proposed anti- and pro-inflammatory properties,
respectively, were measured by two-site ELISA in the serum of patients with aggressive periodontitis (AgP, n = 30), chronic
periodontitis (CP, n = 29) and periodontally healthy controls (H, n = 28). Furthermore, Hsp27 and Hsp60 levels were also
measured longitudinally in 12 AgP patients at 6 time points up to 3 months after treatment. AgP patients had lower levels of
Hsp27 compared to CP patients and healthy subjects (adjusted one-way ANOVA, p < 0.001, followed by post hoc Tukey HSD
comparisons), while no differences in levels of Hsp60 or cytokines between the three groups were detected. In CP patients and H
subjects, the systemic Hsp27 levels correlated with Hsp60 (r = 0.43, p < 0.001; r = 0.59, p < 0.001, respectively) and with pro-
inflammatory cytokines TNF-α (r = 0.48, p < 0.001; r = 0.55, p < 0.001, respectively) and IL-6 (r = 0.44, p < 0.01). However, no
such correlations were detected in AgP cases. No consistent temporal patterns of changes of Hsp27 concentration were detected
across AgP patients following periodontal treatment. This study provides the first evidence that Hsp27 may be differentially
expressed and regulated in AgP patients as compared with CP patients and healthy individuals.
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Introduction
The periodontal diseases are the world’s most common
chronic inflammatory diseases (Eke et al. 2012) and are cur-
rently subdivided into a number of diagnostic categories
(Armitage 2004). Of these, the two principal forms of
periodontitis, chronic (CP) and aggressive periodontitis
(AgP), have been suggested to differ in clinical appearance
and disease progression (Armitage and Cullinan 2010).
However, objective clinical measures have thus far failed to
discriminate between these two perceived conditions
(Frydman and Simonian 2011). For example, these gingival
diseases cannot be histologically (Smith et al. 2010) or micro-
biologically (Armitage 2010) discriminated, and analysis of
gene expression profiles (Kebschull et al. 2013) or measures
of systemic inflammation (Cairo et al. 2010) have not proved
diagnostically discriminatory.
There is a very large number of proposed diagnostic and
prognostic biomarkers, although very few of them have
bridged the translational gap in inflammatory diseases
(Mischak et al. 2012). One of the most intriguing groups of
potential biomarkers are cell stress proteins. These include
various families of protein-folding proteins known as molec-
ular chaperones and protein-folding catalysts whose intracel-
lular levels havemostly been reported to increase in stressed cells
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(Saibil 2013). However, several studies have observed a decrease
in intracellular Hsp70 and Hsp90 levels in monocytes and poly-
morphonuclear cells, along with a pattern of early extracellular
induction in acute conditions like sepsis (Vardas et al. 2014;
Papadopoulos et al. 2017; Spanaki et al. 2018). It is rapidly
becoming established that these proteins are pivotal controllers
of cellular proteostasis, the network of competing and integrated
biological pathways that controls protein biogenesis, folding,
trafficking and degradation. Defective proteostasis is associated
with cell and tissue pathology (Jovaisaite et al. 2014; Wang et al.
2014). It has been recognised since the 1970s that cell stress
proteins can be secreted by cells and can enter into the circulation
(Henderson and Pockley 2005). In more recent years, cell stress
proteins have been proposed as useful biomarkers (Henderson
and Pockley 2012). For example, Hsp72 levels were able to
discriminate sepsis from systemic inflammatory response syn-
drome (SIRS) and furthermore, they were strong predictors of
mortality (Vardas et al. 2017). Unlike some other biomarkers,
cell stress proteins exert potent intercellular signalling activities
with properties resembling both pro- or anti-inflammatory cyto-
kines (Henderson and Pockley 2010; Pockley and Henderson
2018).
In a previous trial, our group assayed plasma obtained from
patients with chronic periodontitis and control subjects for sys-
temic levels of a number of cell stress proteins, Hsp10, Hsp60
and BiP (Henderson and Pockley 2010). Levels of Hsp10 and
BiP were significantly lower in the blood of patients compared
with controls, while Hsp60 levels were similar in both groups.
Effective treatment of periodontitis was associated with a sig-
nificant increase in Hsp10 levels to those found in controls and
a lesser increase in BiP levels with no change in Hsp60. This
initial evidence shows the potential importance of circulating
cell stress proteins in periodontitis and its response to treatment.
In this study, we concentrated on another cell stress protein,
the myeloid cell-modulating cell stress protein Hsp27, which
has been described to exert anti-inflammatory activities
(De et al. 2000; Laudanski et al. 2007). The main outcome
was Hsp27 serum concentration and the null hypothesis was
that systemic Hsp27 and Hsp60 levels do not vary in AgP and
CP, as compared to healthy subjects. Furthermore, we explored
associations between Hsp27 and Hsp60 and key inflammatory
and anti-inflammatory cytokines as well as longitudinal
changes in Hsp27 following periodontal treatment in AgP.
Methods
Subject selection, clinical evaluation and periodontal
treatment
The analyses described here consisted of a case-control and a
treatment study. Both studies were reviewed and approved by
the UCL/UCLH joint ethics committee (references 05/Q0502/
84 and 07/H0713/74), and suitable individuals referred for
care at the Eastman Dental Hospital gave written informed
consent to take part. All participants were of Caucasian origin.
Exclusion criteria for both studies were presence of other
chronic oral conditions as assessed by the examining clinician:
pregnancy; reported history of medical conditions or concom-
itant systemic medications; intake of anti-inflammatory drugs
or antibiotics within 3 months; known infectious diseases and
previous periodontal therapy within 12 months. At the base-
line visit, the patients’ height, weight and waist circumference
were taken and BMI calculated. A single calibrated exam-
iner measured full-mouth probing pocket depth (PPD),
clinical attachment loss (CAL) and full-mouth bleeding
on probing score (FMBS) at six sites per tooth as previ-
ously described (Guerrero et al. 2005). Repeated measure-
ments of 10 non-study subjects (with at least 15 min
separation) showed 98% intra-examiner repeatability
within 2 mm for PPD.
The case-control study consisted of a total of 87 consecu-
tive ethnically Caucasian subjects drawn from a larger case-
control study, based on the following characteristics:
– Periodontally healthy controls (H, n= 28) with PPD ≤ 4mm
and FMBS <20%
– Chronic periodontitis (CP, n = 29), with at least 10 sites
with PPD > 4 mm
– Aggressive periodontitis (AgP, either localised or gener-
alised, n = 30), with PPD and CAL ≥ 6 mm and bleeding
on probing in at least three sites in different teeth
Periodontitis patients were diagnosed with AgP based on
self-report of familial aggregation and systemic health and on
rapid progression evidenced by either age at diagnosis < 45 years
old or radiographic evidence of bone loss > 1 mm in at least two
non-adjacent sites within a 1-year period (Mombelli et al. 2002).
The treatment study included 12 AgP patients (diagnosed
as above) less than 45 years old. All treatment sessions were
performed by a single qualified periodontist as described
before (Nibali et al. 2013). Briefly, after a baseline visit, full-
mouth non-surgical periodontal therapy (NSPT) was per-
formed under local anaesthesia on day 14, and follow-up oral
hygiene instructions were provided. Patients were reassessed
an average of 30 days after NSPT. On day 70, periodontal
surgical treatment (open-flap debridement, OFD) was per-
formed under local anaesthesia in the worst affected quadrant
(residual > 5 mm PPDs with bleeding on probing). Full-
thickness muco-periosteal flaps were elevated, granulation tis-
sue and subgingival debridement and, if required, localised
non-supporting bone (osteoplasty) removed, and the flaps
were readapted and sutured. Patients were seen for follow-
ups and blood samples taken on day 1, 7, 30, 60 and 90 after
OFD surgery.
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Blood sampling
Blood samples were collected at the baseline visit for both
investigations. For the intervention study, blood samples were
additionally collected at all follow-up appointments. All pa-
tients had been fasting for 6 h prior to blood sampling on all
visits. Blood was collected by venipuncture from the
antecubital vein and serum was immediately separated by
centrifugation. Serum samples were kept frozen at − 80 °C
until the analyses were performed.
Hsp27 measurement
Hsp27 in serum was measured using an in-house-developed
two-site enzyme-linked immunosorbent assay (ELISA).
Briefly, 96-well plates (Immuno MaxiSorp, Nunc) were coat-
ed with a mouse monoclonal anti-HSP27 antibody (clone
2A5, ATGen) at 1 μg/ml in coating buffer (50 mM
carbonate-bicarbonate buffer, pH 9.6) overnight at 4 °C (see
Fig. 1). Plates were washed with wash buffer (PBS, 0.05%
Tween-20), and non-specific binding sites were blocked by
incubation with 2% (w/v) bovine serum albumin (BSA
Chromatopur Immunoassay Grade, MP Biomedicals) in
PBS for 1 h at room temperature. After washing, human re-
combinant Hsp27 protein (ATgen; 0–200 ng/ml) or dilutions
(PBS) of serum samples and controls were added and
incubated for 2 h at room temperature. Plates were washed
extensively with wash buffer and incubated for 2 h at room
temperature with a goat polyclonal anti-Hsp27 antibody
(C-20, Santa Cruz; 1 μg/ml in 0.5% BSA/PBS). After
washing, bound goat anti-hsp27 antibody was detected by
incubation with HRP-conjugated donkey polyclonal anti-
goat IgG (Santa Cruz ssc-2304, mouse and human adsorbed,
40 ng/ml in 0.5% BSA in wash buffer) at room temperature
for 45 min. Binding of conjugated antibody was detected
using TMB substrate (affymetrix/eBioscience), and the reac-
tion was stopped by adding 2 N H2SO4. Absorbance at
450 nm, using a 570-nm reference wavelength, was deter-
mined with a plate reader (MRX II, Dynex). Cytokine con-
centrations were calculated by the plate reader software
(Revelation, Dynex). Each serum sample was assayed in trip-
licate. The assay was highly specific for Hsp27 and showed no
cross-reactivity with recombinant human Hsp10, Hsp60, or
Hsp70 stress proteins and did not cross-react with bovine se-
rum albumin, foetal calf serum or E. coli lipopolysaccharide
(data not shown). The detection limit of the assay was
0.1 ng/ml Hsp27, and the linear range was between 1 and
50 ng/ml Hsp27 (Fig. 3). The intra- and inter-coefficients of
variability were less than 7%. The assay showed almost linear
dilution of serum samples with PBS. The recovery rate of
exogenously added recombinant Hsp27 to serum from donors
with low (1 ng/ml) or medium levels (15 ng/ml) of endoge-
nous Hsp27 was ≥ 95%.
Hsp60 measurement
Hsp60 was measured by ELISA as previously described
(Shamaei-Tousi et al. 2006) with few modifications. Hsp60
in serum or recombinant Hsp60 protein (ATgen; 0–5 μg/ml)
was captured with a mouse monoclonal anti-Hsp60 antibody
(clone LK1, Stressgen; 1 μg/ml). A goat polyclonal anti-
Hsp60 antibody (Stressgen; 1 μg/ml) was used as detection
antibody, followed by incubation with a biotinylated donkey
polyclonal anti-goat IgG (Alpha Diagnostics, 1:5000). Bound
secondary antibody was detected with Streptavidin-HRP
(Biolegend; 0.25 μg/ml). The assay was developed with
TMB substrate (affymetrix/eBioscience), and the reaction
stopped with 2 N H2SO4.
Cytokine measurements
Serum levels of IL-1β, IL-6, IL-10 and TNF-αwere measured
by two-site ELISA using commercial kits according to the
manufacturer’s recommendations (Human Ready-SET-Go!®
ELISA, affymetrix/eBioscience).
Statistical analysis
Since no data on Hsp27 relative to periodontal disease are
available in the literature, no formal sample size calculation
was performed. All data were analysed using SPSS Statistics
software package (V24, IBM). Differences in the characteris-
tics between the case-control study groups were computed
Fig. 1 Evaluation of the Hsp27 immunoassay (ELISA). The graph, a
representative standard curve of the Hsp27 ELISA assay, shows the
measurement of serial dilutions (1:2 in PBS) of recombinant Hsp27
starting at a concentration of 400 ng/ml. Input rHsp27 concentrations
(ng/ml) are plotted versus optical density (OD600) after assay
development, with both axes on log2 scale. Error bars show the
standard deviation of triplicate sample measurements
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with parametric (independent-samples t test) or non-
parametric (Mann-Whitney U Test) tests dependent upon the
data frequency distribution and equality and homogeneity of
variance tests. Categorical variables were analysed by chi-
square testing. Because the distribution of heat-shock protein
and cytokine concentrations in blood was markedly skewed,
data was natural log-transformed (LN) (after adding a con-
stant) to achieve a more normal distribution prior to statistical
analysis. Differences in analyte concentrations between sub-
ject groups were analysed by parametric independent-samples
t tests or one-way between-group (ANOVA) tests followed by
a post hoc comparison using the Tukey HSD test. Parametric
correlation analysis (Pearson) was performed to evaluate the
association between cytokine and heat-shock protein concen-
trations in serum. Age, gender, BMI and cigarette smoking
were included in all models as covariates. A two-sided value
of p < 0.05 was considered statistically significant.
Results
Case-control-study
The main characteristics of AgP and CP patients and healthy
controls are reported in Table 1. Baseline concentrations of
systemic levels of the pro-inflammatory cytokines IL-1, IL-6
and TNF-α and the anti-inflammatory cytokine IL-10 were
compared between healthy subjects and patients diagnosed
with AgP or CP (Fig. 2). There was no statistically significant
difference in the cytokine levels between the three groups for
IL-1 (p = 0.078; Kruskal-Wallis test), IL-6 (p = 0.39;
ANOVA) and IL-10 (p = 0.93; ANOVA). TNF-α levels were
reduced in AgP patients (p = 0.02; ANOVA).
Hsp60 serum concentrations were not significantly differ-
ent (p = 0.172, one-way ANOVA) between healthy individ-
uals and patients with periodontitis (Fig. 3). The analysis of
Hsp27 concentrations in the serum of H, AgP or CP patients
revealed a statistically significant difference between the three
subject groups (one-way ANOVA, p < 0.001) (Fig. 4). Post
hoc tests (Tukey HSD) indicated that patients diagnosed with
AgP had significantly less Hsp27 (M = 0.62, SD = 0.97) in
their circulation than healthy subjects (M = 1.68, SD = 0.97)
or CP patients (M = 1.59, SD = 0.84). We further analysed the
effect of possible known confounding factors (age, gender,
BMI, smoking, and PPD > 4 mm) on Hsp27 levels. Standard
multiple regression analysis identified smoking as a con-
founding factor for Hsp27 serum levels (p = 0.004).
However, after adjustment for smoking, age, gender, BMI
and number of PPD, the detected association between
AgP and Hsp27 levels remained statistically significant
(ANCOVA, p = 0.013).
The relationship between serum concentrations of systemic
stress proteins (Hsp27, Hsp60) and cytokines (IL-1, IL-6,
TNF-α, IL-10) in healthy individuals and CP or AgP patients
Table 1 Comparison of
demographic characteristics,
clinical parameters and serum
baseline measurements of patients
and control subjects
AgP CP H p value
Cases [n] 30 29 28
Age [years] 35.5 (5.0) 42.2 (8.2) 39.4 (11.2) 0.011
Male gender [%] 30 37.9 32.1 0.801
Smokers current [%] 46.7 37.9 10.7 0.01
BMI 26.4 (7.0) 25.4 (6.0) 22.8 (2.2) 0.036
Sites with PPD > 4 mm [n] 67.5 (39.2) 44.1 (24.9) 0 < 0.001
IL-1 [pg/ml] 7.9 (107.8) 13.4 (247.3) 16.9 (122.1) 0.078
IL-6 [pg/ml] 1.9 (39.0) 2.7 (22.4) 1.2 (10.8) 0.039
TNF [pg/ml] 2.4 (104.6) 7.8 (192.2) 6.9 (37.4) 0.02
IL-10 [pg/ml] 2.9 (19.5) 4.2 (83.7) 3.5 (7.8) 0.093
Hsp60 [ng/ml] 51.3 (9088) 136.7 (10,000.0) 90.3 (3023.3) 0.172
Hsp27 [ng/ml] 1.7 (25.0) 4.7 (37.6) 4.9 (3.5) < 0.001
The table shows the characteristics of subjects included in both studies. Continuous demographic and clinical
variables (age, BMI and PPD) are reported as mean and standard deviation, serum analytes (IL-1, IL-6, TNF,
IL-10, Hsp60, Hsp27) as median and interquartile range. The last column reports the statistical significance
(p value) of the differences between the three groups. Categorical variables were analysed by chi-square test for
independence. The differences for continuous variables were computed with parametric (one-way between-
groups ANOVA) or non-parametric (Kruskal-Wallis) tests dependent upon the data frequency distribution.
Serum analyte data were transformed as described in the “Material and methods” section prior to statistical
analysis
AgP aggressive periodontitis, CP chronic periodontitis, H healthy subjects, BMI body mass index, PPD pocket
probing depth
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(Table 2) was investigated using Pearson correlation coeffi-
cient analyses. Preliminary analyses were performed to ensure
no violation of the assumptions of normality, linearity and
homoscedasticity. We observed complex patterns of positive
associations which markedly differed across the subject
groups. In both AgP and CP but not H subjects, strong asso-
ciations between IL-1 and IL-10 or TNF-α (r > 0.52,
p < 0.01), as well as between IL-10 and TNF-α (r > 0.47,
p < 0.01), were detected. The association patterns of Hsp60 were
similar between the three subject groups: Hsp60 showed a strong
positive association with both IL-6 and TNF-α (r > 0.53,
p < 0.01), but only weak associations with IL-1 and IL-10 in
all groups. In sharp contrast, Hsp27 levels were strongly associ-
ated with Hsp60 and TNF-α (r> 0.43, p < 0.01) in healthy indi-
viduals and CP patients, whereas no such associations could be
revealed in AgP patients.
Treatment study
Hsp60 and Hsp27 serum levels were measured in patients
with AgP (n = 12) at various time points after induction of
periodontal therapy (as described in the “Material and
methods” section). The concentration of Hsp60 in the se-
rum of these patients remained largely unchanged upon
periodontal treatment (data not shown). In sharp contrast,
these patients showed profound and highly dynamic
changes in circulating Hsp27 levels after non-surgical
(NSPT) and surgical (OFD) treatment (Fig. 5). However,
the temporal patterns resulting from fluctuating Hsp27
levels after treatment were highly heterogeneous across
AgP patients and no consistent direction or magnitude of
Hsp27 response could be observed in the treatment time
points investigated.
Fig. 2 a–d Pro- and
anti-inflammatory cytokine
concentrations in the circulation
were similar between healthy
subjects and patients with
different forms of periodontitis.
Cytokine concentrations in serum
of healthy subjects (H, n = 28)
and patients diagnosed with
periodontitis classified into
aggressive periodontitis (AgP,
n = 29) and chronic periodontitis
(ChP, n = 29). The concentrations
of IL-1 (a), IL-6 (b), TNF-α (c)
and IL-10 (d) were measured by
two-site ELISA. The data
distribution of transformed
cytokine concentration is
visualised as box-and-whisker
plots (SPSS). The boxes represent
the interquartile range and the line
inside the box refers to the median
value. The whiskers extend to the
smallest and largest values within
1.5 times the interquartile range;
outliers (as defined by SPSS) are
visualised as open circles
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Discussion
This study is the first to suggest that systemic concentrations
of Hsp27 may differ between different types of periodontal
disease. Periodontitis is characterised by the development of
an exacerbated host inflammatory response leading to destruc-
tion of tooth-supporting hard and soft tissue and, ultimately, to
tooth loss. Its prevalence is high and currently increasing in
industrialised populations, with a recently increased preva-
lence of severe periodontitis up to nearly 10% (Eke et al.
2012). Based on recent surveys, approximately half of the
US and half of the UK population suffer from periodontitis
(Eke et al. 2012). Periodontitis is heterogeneous and currently
classified into two main forms: chronic periodontitis (CP) and
the rarer aggressive periodontitis (AgP) which is estimated to
affect approximately 1–2% of individuals (Albandar and
Tinoco 2002). AgP usually affects younger systemically
healthy individuals and has a more rapid rate of progression.
However, there is currently no objective biomarker-based di-
agnostic tool or sufficiently distinct histopathological charac-
teristics to discriminate the two forms of periodontitis
(Armitage and Cullinan 2010), so the current classification is
under revision.
Molecular chaperones, also referred to as “cell stress pro-
teins” or “heat shock proteins” (HSPs)—as their levels often
increase during cell stress (such as elevated temperature), in-
clude a repertoire of functions such as de novo protein folding,
disaggregation and protein trafficking. Initially, cell stress pro-
teins were assumed to be purely intracellular proteins (Wick
et al. 2004; Henderson and Pockley 2005). However, it has
been demonstrated that in addition to their intracellular
chaperoning functions, cell stress proteins can be released by
cells and exist on the outer plasma membrane or in extracel-
lular environments such as body fluids (Panayi et al. 2004).
These secreted versions of cell stress proteins are found in the
circulation in health and in a range of diseases and are increas-
ingly being used as biomarkers in human disease states.
Currently, we have most information about the role of circu-
lating cell stress proteins in the cardiovascular diseases
(Shamaei-Tousi et al. 2007b; Henderson and Pockley 2012)
and in acute conditions like sepsis (Vardas et al. 2014,
Briassouli et al. 2014). The secreted versions of stress proteins
are hypothesised to have a broad spectrum of biological activ-
ities, depending on the particular protein and its concentration.
Numerous studies have demonstrated that cell stress proteins
have potent intercellular signalling actions for example with
Fig. 3 Systemic levels of Hsp60 were similar in healthy individuals and
patients with different forms of periodontitis. The concentration of Hsp60
in the serum was measured by two-site ELISA. The distribution of
transformed Hsp60 concentrations in the serum of healthy subjects (H,
n = 28) and patients diagnosed with chronic (ChP, n = 29) or aggressive
(AgP, n = 30) periodontitis is visualised as box-and-whisker plots (SPSS)
Fig. 4 Patients diagnosed with aggressive periodontitis had significantly
lower levels of Hsp27 in their circulation. The concentration of Hsp27 in
the serum of healthy donors (n = 28), patients with chronic (n = 29) or
aggressive (n = 30) periodontitis, was measured by two-site ELISA. The
box-and-whisker plot shows the distribution of Hsp27 concentrations
after transformation
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leukocytes and vascular endothelial cells, with activity pro-
files similar to those of pro- and anti-inflammatory cytokines
(also referred to as “chaperokine” function) (Henderson and
Pockley 2010). This suggests that cell stress proteins may
function, like cytokines, as extracellular homeostatic control
proteins or as homeostatic controllers of immunity
(Henderson 2010; Henderson and Kaiser 2013). For example,
the secreted pro-inflammatory cell stress protein cyclophilin A
has been proposed as a therapeutic target in atherosclerosis
(Bukrinsky et al. 2013) as well as a diagnostic maker for
vascular disease in type 2 diabetes (Ramachandran and
Kartha 2012). The heat-shock protein Hsp10 and the endo-
plasmic reticulum molecular chaperone BiP (HSPA8) have
been demonstrated to have significant anti-inflammatory
actions (Vanags et al. 2006; Panayi and Corrigall 2014) and
both are currently undergoing clinical investigation. However,
the role of other stress proteins such as Hsp72 is still less clear,
with human studies showing either a protective role or an
association with mortality and infections in sepsis
(Briassoulis et al. 2014; Levada et al. 2018).
With regard to the role of secreted cell stress proteins in
periodontitis, both bacterial and host heat-shock proteins are
hypothesised to contribute to pathology. To date, only a few
studies have investigated the potential role of circulating
levels of human cell stress proteins in the periodontal disease
pathogenesis (Nethravathy et al. 2014; Tsybikov et al. 2014).
Notably, our group has demonstrated that circulating levels of
Hsp10 and of BiP, both considered anti-inflammatory agents,
were significantly higher in healthy controls than in patients
with periodontitis, suggesting that these two cell stress
proteins were either not being secreted or were being re-
moved from the circulation in patients with periodontitis
(Shamaei-Tousi et al. 2007a).
Hsp27 is a major intracellular molecular chaperone and
controller of intracellular responses to inflammatory signals
(Alford et al. 2007). Recombinant Hsp27 is also able to mod-
ulate myeloid cell activity with the protein showing an anti-
inflammatory mode of action in vitro (De et al. 2000).
Furthermore, Hsp27 in the circulation has been demonstrated
to function as an atheroprotective protein by preventing the
release of inflammatory cytokines (Rayner et al. 2009;
Józefowicz-Okonkwo et al. 2009). Hsp27 is also expressed
in numerous human cancers, and its expression seems to cor-
relate with poor clinical outcome (Ciocca and Calderwood
2005). In particular, treatments aimed at modulating Hsp27
levels and particularly its effects on apoptosis are being
experimented on for prostate cancer treatment (Yu et al.
2017). The role of systemic Hsp27 in periodontitis is currently
unknown and we are not aware of any studies investigating it.
Interestingly, the serum concentrations of key cytokines,
typically involved in the induction and resolution of inflam-
matory processes, failed to distinguish between disease status
or between the two forms of the disease, AgP and CP, respec-
tively. Notably, we found that the concentration of Hsp27 in
peripheral blood in AgP patients was significantly lower than
in CP patients or in healthy controls. This finding suggests that
in AgP patients, either less Hsp27 is being secreted or Hsp27
is being removed from the circulation at a greater than normal
rate (Lebherz-Eichinger et al. 2012). In line with the described
promotion of anti-inflammatory signalling by released Hsp27
(De et al. 2000; Rayner et al. 2008), the identified lower levels
of this stress protein in the blood of AgP patients may result in
impaired immune-dampening activity thereby contributing to
an exacerbation of periodontal disease.
Our (Nibali et al. 2013) and other groups (Becerik et al.
2012; Mattuella et al. 2013) have previously investigated to
which extent local and systemic levels of cytokines may con-
tribute to the manifestation of severe periodontal disease. We
have also proposed the hypothesis that cell stress proteins and
cytokines generate complex intra- and extracellular networks,
which function in the control of cells to external and internal
stressors (Henderson andKaiser 2013; Kaiser et al. 2014). The
existence of such networks would suggest that the cell stress
Table 2 Associations between circulating heat-shock proteins Hsp27
and Hsp60 and cytokines in healthy controls and patients with
periodontitis
Hsp27 Hsp60 IL-1 IL-6 IL-10
a. H
Hsp60 0.599**
IL-1 0.059 0.177
IL-6 0.353 0.381* − 0.132
IL-10 0.09 − 0.118 0.058 0.562**
TNF 0.553** 0.753** 0.326 0.321 0.007
n 28 28 28 27 27
b. CP
Hsp60 0.439*
IL-1 0.254 0.377*
IL-6 0.446* 0.538** 0.346
IL-10 0.357 0.374* 0.525** 0.453*
TNF 0.482** 0.672** 0.545** 0.453* 0.479**
n 29 29 29 29 29
c. AgP
Hsp60 0.33
IL-1 0.084 0.343
IL-6 − 0.031 0.455* 0.637**
IL-10 0.064 0.313 0.632** 0.620**
TNF 0.193 0.557** 0.576** 0.688** 0.698**
n 29 29 29 29 29
The tables show the R values of the parametric correlation analysis
(Pearson) for serum levels of Hsp27, Hsp60 and cytokines IL-1, IL-6,
IL-10 and TNF in (a) healthy subjects, (b) patients diagnosed with chronic
periodontitis and (c) patients with aggressive periodontitis
Correlation is significant at the **p < 0.01 level (two-tailed); *p < 0.05
level (two-tailed)
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response is a key parameter in cytokine network generation
and, as a consequence, in control of immunity. This raises the
question whether the two heat-shock proteins investigated in
this study, Hsp27 and Hsp60, may be part of a cell stress
protein-cytokine network controlling inflammation in peri-
odontal disease. Interestingly, when we analysed the associa-
tion between circulating levels of Hsp27 and concentrations of
key cytokines involved in the onset of inflammation (IL-1β,
IL-6, TNF-α) as well as resolution of inflammation (IL-10),
we detected distinct differences in the HSP-cytokine associa-
tions between healthy subjects, CP and AgP patients. While
Hsp27 correlated positively with Hsp60, TNF-α and to a less-
er extent IL-6 in both healthy subjects and CP patients, there
were no associations for Hsp27 detectable in the AgP
subgroup. In sharp contrast to the Hsp27-cytokine associa-
tions, Hsp60 concentrations correlated positively with IL-6
and IL-10 levels in all groups. These results support the hy-
pothesis that highly complex HSP-cytokine networks control
the inflammatory processes in periodontal diseases and em-
phasise that the composition or function of such networks may
be different in clinically distinct forms of periodontitis.
Treatment of AgP patients resulted in significant changes
in circulating hsp27 levels in all individuals. Interestingly, the
temporal Hsp27 response patterns were highly dynamic,
showing that its levels both increased and decreased by differ-
ent magnitude after individual treatments. However, no clear
pattern of change was observed across all treated cases. As no
untreated controls were available for comparison, it is not
clear whether the observed changes were due to periodontal
treatment or were part of normal fluctuations of Hsp27 sys-
temic concentrations.
The lack of associations between Hsp27 and cytokines sug-
gests that this particular heat-shock protein may prospectively
be investigated as a novel, possibly cytokine-independent,
molecular regulator for the resolution of inflammation in peri-
odontitis. One hypothesis is that stress proteins are interacting
with pro-inflammatory target cells in an attempt to dampen
their activity and control inflammation and, in essence, are
being used up. However, it should be noted that the trauma
and release of a huge burden of microbes from the gingival
pockets upon treatment also has the potential to influence
directly the expression and release of Hsp27 into the circula-
tion. Further studies in large cohorts need to investigate sys-
temic levels of heat-shock proteins after periodontal treatment
(Shamaei-Tousi et al. 2007a).
Limitations of this study include absence of untreated con-
trols in the treatment part, absence of investigation of local (oral
or subgingival) Hsp27 levels and a relatively limited sample
size. The strengths lie in the analysis of a range of periodontal
phenotypes (healthy, AgP, CP) and a range of cytokines and
heat-shock proteins, including the novelty of Hsp27 analysis.
Our finding that the concentration of Hsp27 in the serum of
patients with periodontitis significantly differs between distinct
forms of the disease suggests that this protein may be
Fig. 5 Periodontal treatment in patients with aggressive periodontitis
induces complex and dynamic changes of Hsp27 concentration in their
circulation. The graph shows Hsp27 concentrations in the serum of 12
AgP patients who have undergone periodontal treatment. Hsp27
concentrations (fold-change) are shown over time as compared to
baseline (BL) Hsp27 levels determined in serum samples taken prior to
periodontal treatment. Hsp27 was measured 6 weeks (pre) after non-
surgical periodontal treatment (NSPT) and 1 and 7 days (d) and 1, 2
and 3 months (m) after periodontal surgery (OFD, open-flap
debridement performed 2 months post-NSPT)
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differently regulated in different forms of periodontitis. This
finding should be investigated in independent larger popula-
tions, should be extended to other HSPs and should include
analysis of local/intracellular HSP levels, before the possible
pathogenic effect of Hsp27 and its potential to serve as a
biomarker for clinical purposes are considered.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Albandar JM, Tinoco EMB (2002) Global epidemiology of peri-
odontal diseases in children and young persons. Periodontol
2000 29:153–176
Alford KA, Glennie S, Turrell BR et al (2007) Heat shock protein 27
functions in inflammatory gene expression and transforming growth
factor-beta-activated kinase-1 (TAK1)-mediated signaling. J Biol
Chem 282:6232–6241. https://doi.org/10.1074/jbc.M610987200
Armitage GC (2004) Periodontal diagnoses and classification of peri-
odontal diseases. Periodontol 2000 34:9–21
Armitage GC (2010) Comparison of the microbiological features of
chronic and aggressive periodontitis. Periodontol 2000 53:70–88.
https://doi.org/10.1111/j.1600-0757.2010.00357.x
Armitage GC, Cullinan MP (2010) Comparison of the clinical features of
chronic and aggressive periodontitis. Periodontol 2000 53:12–27.
https://doi.org/10.1111/j.1600-0757.2010.00353.x
Becerik S, Öztürk VÖ, Atmaca H, Atilla G, Emingil G (2012) Gingival
crevicular fluid and plasma acute-phase cytokine levels in different
periodontal diseases. J Periodontol 83:1304–1313. https://doi.org/
10.1902/jop.2012.110616
Briassouli E, Goukos D, Daikos G, Apostolou K, Routsi C, Nanas S,
Briassoulis G (2014) Glutamine suppresses Hsp72 not Hsp90α
and is not inducing Th1, Th2, or Th17 cytokine responses in human
septic PBMCs. Nutrition 30(10):1185–1194. https://doi.org/10.
1016/j.nut.2014.01.018
Briassoulis G, Briassouli E, Fitrolaki DM, Plati I, Apostolou K, Tavladaki T,
Spanaki AM (2014) Heat shock protein 72 expressing stress in sepsis:
unbridgeable gap between animal and human studies—a hypothetical
“comparative” study. Biomed Res Int 2014:101023–101017.
https://doi.org/10.1155/2014/101023
Bukrinsky M, Orekhov A, Ditiatkovski M, Sviridov D (2013)
Cyclophilins in atherosclerosis: a new therapeutic target? Curr
Pharm Des 19:5904–5908
Cairo F, Nieri M, Gori AM, Tonelli P, Branchi R, Castellani S, Abbate R,
Pini-Prato GP (2010) Markers of systemic inflammation in peri-
odontal patients: chronic versus aggressive periodontitis. An explor-
ative cross-sectional study. Eur J Oral Implantol 3:147–153
Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diag-
nostic, prognostic, predictive, and treatment implications. Cell
Stress Chaperones 10:86–103
De AK, Kodys KM, Yeh BS, Miller-Graziano C (2000) Exaggerated
human monocyte IL-10 concomitant to minimal TNF-alpha induc-
tion by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily
an antiinflammatory stimulus. J Immunol 165:3951–3958
Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, CDC
Periodontal Disease Surveillance workgroup: James Beck
(University of North Carolina, Chapel Hill, USA), Gordon
Douglass (Past President, American Academy of Periodontology),
Roy Page (University of Washin) (2012) Prevalence of periodontitis
in adults in theUnited States: 2009 and 2010. J Dent Res 91:914–920.
https://doi.org/10.1177/0022034512457373
Frydman A, Simonian K (2011) Aggressive periodontitis: the historic
quest for understanding. J Calif Dent Assoc 39:377–382
Guerrero A, Griffiths GS, Nibali L, Suvan J,Moles DR, Laurell L, Tonetti
MS (2005) Adjunctive benefits of systemic amoxicillin and metro-
nidazole in non-surgical treatment of generalized aggressive peri-
odontitis: a randomized placebo-controlled clinical trial. J Clin
Periodontol 32:1096–1107. https://doi.org/10.1111/j.1600-051X.
2005.00814.x
Henderson B (2010) Integrating the cell stress response: a new view of
molecular chaperones as immunological and physiological homeo-
static regulators. Cell Biochem Funct 28:1–14. https://doi.org/10.
1002/cbf.1609
Henderson B, Kaiser F (2013) Do reciprocal interactions between cell
stress proteins and cytokines create a new intra-/extra-cellular sig-
nalling nexus? Cell Stress Chaperones 18:685–701. https://doi.org/
10.1007/s12192-013-0444-9
Henderson B, Pockley AG (2005) Molecular chaperones and cell signal-
ling. Cambridge University Press. Cambridge, UK
Henderson B, Pockley AG (2010) Molecular chaperones and protein-
folding catalysts as intercellular signaling regulators in immunity
and inflammation. J Leukoc Biol 88:1–18. https://doi.org/10.1189/
jlb.1209779
Henderson B, Pockley AG (2012) Proteotoxic stress and circulating cell
stress proteins in the cardiovascular diseases. Cell Stress Chaperones
17:303–311. https://doi.org/10.1007/s12192-011-0318-y
Jovaisaite V, Mouchiroud L, Auwerx J (2014) The mitochondrial unfold-
ed protein response, a conserved stress response pathway with im-
plications in health and disease. J ExpBiol 217:137–143. https://doi.
org/10.1242/jeb.090738
Józefowicz-Okonkwo G, Wierzbowska-Drabik K, Kasielski M, Trzos E,
Goraca A, Nowak D, Kasprzak J, Krzemińska-Pakuła M (2009) Is
Hsp27 a marker of myocardial ischaemia? Kardiol Pol 67:947–952
Kaiser F, Steptoe A, Thompson S, Henderson B (2014) Monocyte cyto-
kine synthesis in response to extracellular cell stress proteins sug-
gests these proteins exhibit network behaviour. Cell Stress
Chaperones 19:135–144. https://doi.org/10.1007/s12192-013-
0440-0
Kebschull M, Guarnieri P, Demmer RT, Boulesteix AL, Pavlidis P,
Papapanou PN (2013) Molecular differences between chronic and
aggressive periodontitis. J Dent Res 92:1081–1088. https://doi.org/
10.1177/0022034513506011
Laudanski K, De A, Miller-Graziano C (2007) Exogenous heat shock
protein 27 uniquely blocks differentiation of monocytes to dendritic
cells. Eur J Immunol 37:2812–2824. https://doi.org/10.1002/eji.
200636993
Lebherz-Eichinger D, Ankersmit HJ, Hacker S, Hetz H, Kimberger O,
Schmidt EM, Reiter T, Hörl WH, Haas M, Krenn CG, Roth GA
(2012) HSP27 and HSP70 serum and urine levels in patients suffer-
ing from chronic kidney disease. Clin Chim Acta 413:282–286.
https://doi.org/10.1016/j.cca.2011.10.010
Levada K, Guldiken N, Zhang X, et al. (2018) Hsp72 protects against
liver injury via attenuation of hepatocellular death, oxidative stress,
and JNK signaling. J Hepatol. doi: https://doi.org/10.1016/j.jhep.
2018.01.003.
Mattuella LG, Campagnaro MB, Vargas AE, Xavier LL, Oppermann RV,
Chies JAB, Miranda LA (2013) Plasma cytokines levels in aggres-
sive and chronic periodontitis. Acta Odontol Scand 71:683–688.
https://doi.org/10.3109/00016357.2012.715191
Association between circulating levels of heat-shock protein 27 and aggressive periodontitis
Mischak H, Ioannidis JPA, Argiles A, Attwood TK, Bongcam-Rudloff E,
Broenstrup M, Charonis A, Chrousos GP, Delles C, Dominiczak A,
Dylag T, Ehrich J, Egido J, Findeisen P, Jankowski J, Johnson RW,
Julien BA, Lankisch T, Leung HY, Maahs D, Magni F, Manns MP,
Manolis E,Mayer G, Navis G, Novak J, Ortiz A, Persson F, Peter K,
Riese HH, Rossing P, Sattar N, Spasovski G, Thongboonkerd V,
Vanholder R, Schanstra JP, Vlahou A (2012) Implementation
of proteomic biomarkers: making it work. Eur J Clin Investig
42:1027–1036. https://doi.org/10.1111/j.1365-2362.2012.02674.x
Mombelli A, Casagni F, Madianos PN (2002) Can presence or absence of
periodontal pathogens distinguish between subjects with chronic
and aggressive periodontitis? A systematic review. J Clin
Periodontol 29(Suppl 3):10–21–8
Nethravathy RR, Alamelu S, Arun K, Kumar T (2014) Evaluation of
circulatory and salivary levels of heat shock protein 60 in periodon-
tal health and disease. Indian J Dent Res 25:300–304. https://doi.
org/10.4103/0970-9290.138317
Nibali L, Pelekos G, D’Aiuto F, Chaudhary N, Habeeb R, Ready D,
Parkar M, Donos N (2013) Influence of IL-6 haplotypes on clinical
and inflammatory response in aggressive periodontitis. Clin Oral
Investig 17:1235–1242. https://doi.org/10.1007/s00784-012-0804-3
Panayi GS, Corrigall VM (2014) Immunoglobulin heavy-chain-binding
protein (BiP): a stress protein that has the potential to be a novel
therapy for rheumatoid arthritis. Biochem Soc Trans 42:1752–1755.
https://doi.org/10.1042/BST20140230
Panayi GS, Corrigall VM, Henderson B (2004) Stress cytokines: pivotal
proteins in immune regulatory networks. OpinCurr Opin Immunol
16(4):531–534. https://doi.org/10.1016/j.coi.2004.05.017
Papadopoulos P, Pistiki A, Theodorakopoulou M, Christodoulopoulou T,
Damoraki G, Goukos D, Briassouli E, Dimopoulou I, Armaganidis
A, Nanas S, Briassoulis G, Tsiodras S (2017) Immunoparalysis:
clinical and immunological associations in SIRS and severe sepsis
patients. Cytokine 92:83–92. https://doi.org/10.1016/j.cyto.2017.
01.012.
Pockley AG, Henderson B (2018) Extracellular cell stress (heat shock)
proteins—immune responses and disease: an overview. Philos Trans
R Soc B Biol Sci 373:20160522. https://doi.org/10.1098/rstb.2016.
0522
Ramachandran S, Kartha CC (2012) Cyclophilin-a: a potential screening
marker for vascular disease in type-2 diabetes. Can J Physiol
Pharmacol 90:1005–1015. https://doi.org/10.1139/y2012-038
Rayner K, Chen Y-X,McNultyM, Simard T, Zhao X,Wells DJ, de Belleroche J,
O'Brien ER (2008) Extracellular release of the atheroprotective heat shock
protein 27 is mediated by estrogen and competitively inhibits acLDL binding
to scavenger receptor-a. Circ Res 103:133–141. https://doi.org/10.1161/
CIRCRESAHA.108.172155
Rayner K, Sun J, Chen Y-X,McNultyM, Simard T, Zhao X,Wells DJ, de
Belleroche J, O'Brien ER (2009) Heat shock protein 27 protects
against atherogenesis via an estrogen-dependent mechanism: role
of selective estrogen receptor beta modulation. Arterioscler
Thromb Vasc Biol 29:1751–1756. https://doi.org/10.1161/
ATVBAHA.109.193656
Saibil H (2013) Chaperone machines for protein folding, unfolding and
disaggregation. Nat Rev Mol Cell Biol 14:630–642. https://doi.org/
10.1038/nrm3658
Shamaei-Tousi A, Stephens JW, Bin R, Cooper JA, Steptoe A, Coates
ARM, Henderson B, Humphries SE (2006) Association between
plasma levels of heat shock protein 60 and cardiovascular disease
in patients with diabetes mellitus. Eur Heart J 27:1565–1570.
https://doi.org/10.1093/eurheartj/ehl081
Shamaei-Tousi A, D’Aiuto F, Nibali L et al (2007a) Differential regula-
tion of circulating levels of molecular chaperones in patients under-
going treatment for periodontal disease. PLoS One 2:e1198. https://
doi.org/10.1371/journal.pone.0001198
Shamaei-Tousi A, Halcox JP, Henderson B (2007b) Stressing the obvi-
ous? Cell stress and cell stress proteins in cardiovascular disease.
Cardiovasc Res 74:19–28. https://doi.org/10.1016/j.cardiores.2006.
10.025
SmithM, Seymour GJ, CullinanMP (2010) Histopathological features of
chronic and aggressive periodontitis. Periodontol 2000 53:45–54.
https://doi.org/10.1111/j.1600-0757.2010.00354.x
Spanaki AM, Tavladaki T, Dimitriou H, et al. (2018) Longitudinal pro-
files of metabolism and bioenergetics associated with innate im-
mune hormonal inflammatory responses and amino-acid kinetics
in severe sepsis and systemic inflammatory response syndrome in
children. JPEN J Parenter Enteral Nutr. 2018. doi: https://doi.org/10.
1002/jpen.1050
Tsybikov NN, Baranov SV, Kuznik BI, Malezhik LP, Isakova NV (2014)
Serum, oral and gingival fluid levels of heat shock protein-70, cyto-
kines and their autoantibodies by periodontal disease. Stomatol
(Mosk) 93:16–18
Vanags D, Williams B, Johnson B, Hall S, Nash P, Taylor A, Weiss J,
Feeney D (2006) Therapeutic efficacy and safety of chaperonin 10
in patients with rheumatoid arthritis: a double-blind randomised tri-
al. Lancet (London, England) 368:855–863. https://doi.org/10.1016/
S0140-6736(06)69210-6
Vardas K, Apostolou K, Briassouli E, Goukos D, Psarra K, Botoula E,
Tsagarakis S, Magira E, Routsi C, Nanas S, Briassoulis G (2014)
Early response roles for prolactin cortisol and circulating and cellu-
lar levels of heat shock proteins 72 and 90α in severe sepsis and
SIRS. Biomed Res Int 2014:803561. https://doi.org/10.1155/2014/
803561
Vardas K, Ilia S, Sertedaki A, Charmandari E, Briassouli E, Goukos D,
Apostolou K, Psarra K, Botoula E, Tsagarakis S, Magira E, Routsi
C, Stratakis CA, Nanas S, Briassoulis G (2017) Increased glucocor-
ticoid receptor expression in sepsis is related to heat shock proteins,
cytokines, and cortisol and is associated with increased mortality.
Intensive Care Med Exp 5(1):10. https://doi.org/10.1186/s40635-
017-0123-8.
Wang W-A, Groenendyk J, Michalak M (2014) Endoplasmic reticulum
stress associated responses in cancer. Biochim Biophys Acta 1843:
2143–2149. https://doi.org/10.1016/j.bbamcr.2014.01.012
Wick G, Knoflach M, Xu Q (2004) Autoimmune and inflammatory
mechanisms in atherosclerosis. Annu Rev Immunol 22:361–403.
https://doi.org/10.1146/annurev.immunol.22.012703.104644
Yu EY, Ellard SL, Hotte SJ, Gingerich JR, Joshua AM, GleaveME, Chi KN
(2017) A randomized phase 2 study of a HSP27 targeting antisense,
apatorsen with prednisone versus prednisone alone, in patients with
metastatic castration resistant prostate cancer. Investig New Drugs.
https://doi.org/10.1007/s10637-017-0553-x
F. Kaiser et al.
